Table 1 Change from baseline in mean MMD over the last 3 months of the DBTP
From: Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
|  | Erenumab (N = 388) | Topiramate (N = 388) | Mean Difference [95% CI] | P-value |
|---|---|---|---|---|
N′ | 387 | 388 |  |  |
Baseline Mean (SD) | 10.34 (4.05) | 10.46 (3.78) | not applicable | not applicable |
Adjusted Mean Change (SE) | −6.13 (0.25) | −4.90 (0.27) | −1.24 [− 1.87; − 0.61] | < 0.001 |